Am J Perinatol 2017; 34(08): 795-800
DOI: 10.1055/s-0037-1598596
Original Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Pentoxifylline Treatment of Very Low Birth Weight Neonates with Nosocomial Sepsis

Şahin Hamilçıkan
1  Department of Pediatrics, Bagcılar Training and Research Hospital, Istanbul, Turkey
,
Emrah Can
1  Department of Pediatrics, Bagcılar Training and Research Hospital, Istanbul, Turkey
,
Övgü Büke
1  Department of Pediatrics, Bagcılar Training and Research Hospital, Istanbul, Turkey
,
Meltem Erol
1  Department of Pediatrics, Bagcılar Training and Research Hospital, Istanbul, Turkey
,
Özlem Bostan Gayret
1  Department of Pediatrics, Bagcılar Training and Research Hospital, Istanbul, Turkey
› Author Affiliations
Further Information

Publication History

02 December 2016

05 January 2017

Publication Date:
14 February 2017 (online)

Abstract

Objective The objective of this study was to assess the result of intravenous pentoxifylline as an adjunct to antibiotic therapy on mortality and morbidity in very low birth weight (VLBW) preterm neonates with nosocomial sepsis.

Methods For the 18 VLBW preterm neonates, as an adjunct therapy to antibiotics regimens, pentoxifylline (5 mg/kg/h for 6 hours) was administered to premature infants with sepsis on 3 successive days. Clinical and laboratory parameters were recorded before and after treatment.

Results Following pentoxifylline therapy, the immature-to-total neutrophil ratio and C-reactive protein (CRP) levels were significantly decreased, while the blood pH and base excess were significantly increased (p < 0.05). The axillary temperature, noninvasive blood pressure, hemoglobin, leukocyte, and thrombocyte values did not significantly differ after treatment (p > 0.05). Coagulase-negative staphylococci (CoNS) (32%), Streptococcus hominis (7.3%), Pseudomonas aeruginosa (5.3%), and Candida parapsilosis (3.1%) were identified in the blood cultures. There were no short-term morbidities (intraventricular hemorrhages, necrotizing enterocolitis, periventricular leukomalacia, and patent ductus arteriosus), no adverse effects, and no mortalities during or after the pentoxifylline therapy in the preterm neonate participants.

Conclusion The CRP levels and heart rate both decreased, while the pH and base excess parameters of the blood gas analysis changed positively after pentoxifylline treatment in VLBW preterm neonates with nosocomial sepsis.

Note

All procedures performed involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and according to the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Şahin Hamilçıkan, Emrah Can, Meltem Erol, and Özlem Bostan Gayret made substantial contributions to the conception and design, acquisition of data or analysis and interpretation of data, drafting the article, and final approval of the version to be published. Övgü Büke helped in revising the article critically for important intellectual content and final approval of the version to be published.